TGen Affiliate, Van Andel Research Institute, Joins with Spectrum Health and Oncology Group 30 July 2010 Cancer patients in West Michigan will soon have the opportunity to access new drugs being developed to fight their disease due to a partnership being formed in Grand Rapids.
Two Multi-Site Collaborative Studies Highlight the Value of 454 Sequencing Systems for Genotyping Applications 30 July 2010 Study used the 454 Genome Sequencer FLX System to perform HIV drug-resistant mutation detection.
Genetix CloneSelect Imager Can Replace MTT Assay for Cytotoxicity 29 July 2010 Independent publication demonstrates significant advantages over conventional approach.
CMS Approves Clinical Study of Genetic Test to Predict Patient Response to Warfarin 27 July 2010 Study to evaluate gene identification ability to predict patient response and improve safety when dosing this anti-blood clotting drug.
Genticel’s Therapeutic Vaccine, ProCervix for HPV Receives Clearance to Start a Phase I Clinical Trial 26 July 2010 Entry into Phase I marks a significant milestone for Genticel, which completed a EUR 13.1 million fund-raising in February 2010.
NSF Funds Research Partnership Between Bioo Scientific and Mirna Therapeutics 22 July 2010 The funding will support tumor regression and pharmacokinetic studies on targeted delivery of microRNAs.
Oncolytics Biotech® Inc. Receives No Objection Letter from Health Canada to Conduct Phase 3 Trial of REOLYSIN® 22 July 2010 The company plans to conduct its Phase 3 trial examining REOLYSIN in combination with paclitaxel and carboplatin in patients with head and neck cancers.
AiCuris Presents Mechanism of Action Investigations of its Anti-HCMV Drug AIC246 22 July 2010 Company announce publication of preclinical data on AIC246, at the International Herpesvirus Workshop in Salt Lake City, Utah.